HUM Humana
company
SEC Filings & Insider Trading Activity 2026

CIK: 49071
Financials
Hospital & Medical Service Plans 41 filings
S&P 500

Latest Humana (HUM) SEC EDGAR filings in 2026 — including the most recent 10-K annual report filed on February 19, 2026, a 10-Q quarterly report filed on November 5, 2025, an 8-K current report filed on April 29, 2026. SignalX aggregates every new 10-K annual report, 10-Q quarterly report, 8-K current report, and Form 4 insider transaction for Humana (HUM) (SEC CIK 49071), with AI-powered section-by-section summaries updated daily.

10-Q: 24
10-K: 9
8-K: 8

Latest 2026 SEC Filing Dates

10-K Annual Report
Feb 19, 2026
10-Q Quarterly Report
Nov 5, 2025
8-K Current Report
Apr 29, 2026

AI 10-K Annual Report Analysis
Latest 10-K (2025-12-31)

Business Overview

  • Core business model: Integrated health insurance services primarily delivering Medicare Advantage and Medicaid plans with complementary healthcare services via CenterWell
  • New emphasis on Medicare Advantage individual plans covering 5.2 million members, including approx. 1.0 million in Florida generating $17.8B premiums (20% of individual MA revenue)
+3 more insights

Management Discussion & Analysis

  • Revenue $129.7B, up 10.1% YoY; premiums $122.8B (+9.6%), services $5.8B (+31.6%), investment income down 17.9% to $1.0B
  • Net income $1.2B, flat YoY (-0.9%); operating margin 2.1% (operating income $2.7B on $129.7B revenue) vs 2.2% in 2024
+5 more insights

Risk Factors

  • CMS 2025 Medicare Advantage Star Ratings declined, risking lower 2026 quality bonus payments and revenues due to pending lawsuit outcome
  • Exposure to geopolitical climate risk from frequent/intense catastrophes including pandemics and hurricanes affecting medical cost trends
+3 more insights

AI 10-Q Quarterly Report Analysis
Latest 10-Q (2025-09-30)

Risk Factors

  • Section 'risk_factors' was empty or not found.

Management Discussion & Analysis

  • Revenue $32.6B Q3 2025, up 11.1% YoY from $29.4B; 9M revenue $97.1B up 9.7% YoY from $88.5B
  • Operating margin declined: income from operations $3.5B Q3 2025 vs $3.1B Q3 2024 (13.1% increase YoY but 45.1% decrease in 9M); benefit ratio 91.1% vs 89.9% Q3, operating cost ratio 12.6% vs 11.5% Q3
Read full Q3 2025 10-Q analysis →

Annual Reports Archive
10-K

AI-powered analysis of Humana (HUM) 10-K annual reports filed with SEC EDGAR.

Quarterly Reports Archive
10-Q

AI-powered analysis of Humana (HUM) 10-Q quarterly reports filed with SEC EDGAR.

Recent 8-K Filings
Current Reports

AI-powered analysis of Humana (HUM) 8-K current reports disclosing material events.

Financial Summary
XBRL

FY2022FY2023FY2024FY2025
Profitability
Revenue$92.9B$106.4B$117.8B$129.7B
Operating Income$3.8B$4.0B$2.6B$2.7B
Net Income$2.8B$2.5B$1.2B$1.2B
Op. Margin4.1%3.8%2.2%2.1%
Net Margin3.0%2.3%1.0%0.9%
Balance Sheet
Total Assets$43.1B$47.1B$46.5B$48.9B
Equity$15.3B$16.3B$16.4B$17.7B
ROE18.3%15.3%7.4%6.7%

Source: XBRL financial data from Humana (HUM) 10-K filings on SEC EDGAR. All figures in USD. Key metrics include revenue, net income, gross profit, gross profit margin, operating income, EPS (diluted), total assets, stockholders' equity, return on equity (ROE), operating cash flow, and capital expenditure.

Latest 2026 SEC Filings — 10-K, 10-Q, 8-K & Form 4

FormFiling DatePeriodAnalysisSEC
8-K
Apr 29, 2026
8-K
Apr 20, 2026
8-K
Apr 10, 2026
8-K
Mar 9, 2026Analysis
8-K
Mar 2, 2026Analysis
10-K
Feb 19, 2026Dec 31, 2025Analysis
8-K
Feb 11, 2026
8-K
Dec 16, 2025
8-K
Dec 1, 2025
10-Q
Nov 5, 2025Sep 30, 2025Analysis
10-Q
Jul 30, 2025Jun 30, 2025Analysis
10-Q
Apr 30, 2025Mar 31, 2025
10-K
Feb 20, 2025Dec 31, 2024
10-Q
Oct 30, 2024Sep 30, 2024
10-Q
Jul 31, 2024Jun 30, 2024
10-Q
Apr 24, 2024Mar 31, 2024
10-K
Feb 15, 2024Dec 31, 2023
10-Q
Nov 1, 2023Sep 30, 2023
10-Q
Aug 2, 2023Jun 30, 2023
10-Q
Apr 26, 2023Mar 31, 2023
10-K
Feb 16, 2023Dec 31, 2022
10-Q
Nov 2, 2022Sep 30, 2022
10-Q
Jul 27, 2022Jun 30, 2022
10-Q
Apr 27, 2022Mar 31, 2022
10-K
Feb 17, 2022Dec 31, 2021

Frequently Asked Questions

What are the latest HUM SEC filings in 2026?

Humana (HUM) has filed a 10-K annual report on February 19, 2026, a 10-Q quarterly report on November 5, 2025, an 8-K current report on April 29, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did HUM file its most recent 10-K annual report?

Humana (HUM) filed its most recent 10-K annual report on February 19, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view HUM 10-Q quarterly reports?

Humana (HUM)'s most recent 10-Q quarterly report was filed on November 5, 2025. SignalX displays every HUM 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has HUM filed recently?

Humana (HUM)'s most recent 8-K was filed on April 29, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find HUM insider trading activity (Form 4)?

SignalX aggregates every HUM Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does HUM file with the SEC?

Humana (HUM) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new HUM filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs — such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Humana (HUM).

What is HUM's SEC CIK number?

Humana (HUM)'s SEC CIK (Central Index Key) number is 49071. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 49071 to look up all HUM filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find HUM return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Humana (HUM) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.

Stay on top of Humana SEC filings

Insider trading data, fund holdings, cross-signal detection, and AI-powered analysis for 41+ filings.